Crossmark

Antitumor immunostimulatory effect via cell-killing action of a novel extracorporeal blood circulating photodynamic therapy system using 5-aminolevulinic acid

Crossref DOI link: https://doi.org/10.1038/s41598-024-84861-8

Published Online: 2025-01-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maegawa, Hidetaka

Kohashi, Masayuki

Harada, Yasuo

Tanaka, Akira

Kajiwara, Shimpei

Fujimoto, Takashi

Atagi, Hidehiro

Kaneda, Kenta
Funding

Funding for this research was provided by:

Otsuka Medical Devices Co., Ltd, Japan
License Information

Text and Data Mining valid from 2025-01-07

Version of Record valid from 2025-01-07
More Information

Article History

Received: 29 March 2024

Accepted: 27 December 2024

First Online: 7 January 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below